Allergen Research Corporation Obtains $17,000,000 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cf05d52e-67b5-4972-86b9-c0d6cadd3fbb - Date
11/22/2013 - Company Name
Allergen Research Corporation - Mailing Address
2000 Alameda De Las Pulgas San Mateo, CA 94403 - Company Description
Allergen Research Corporation (ARC) develops treatments to protect children with food allergies from the threatening consequences of accidental exposure. - Website
http://www.allergenresearch.com - Transaction Type
Venture Equity - Transaction Amount
$17,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
The company intends to use the funds to support its upcoming Phase 2b clinical trial to evaluate peanut allergy oral immunotherapy (OIT) with characterized peanut allergen (CPNA), as well as related development projects. - M&A Terms
- Venture Investor
Longitude Capital Management - Venture Investor
Undisclosed
